Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2017-05-03
2025-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings
NCT00343824
Comparing How Burn Wounds and Scars Heal in Children Using Chitosan and Silver Dressings
NCT06987981
Silver Foam Dressing Superior to Porcine Xenograft in Pediatric Scalds
NCT04410497
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
NCT01636362
An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.
NCT01734317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aquacel
Aquacel hydrocellulose-based dressing applied to partial thickness burns
Aquacel
Hydrocellulose wound dressing
Aquacel AG
Aquacel AG is identical in base composition to Aquacel (ie a hydrocellulose-based wound dressing which adheres to the raw wound surface) but contains 1.2% cationic silver.
Aquacel AG
Hydrocellulose wound dressing containing 1.2% cationic silver
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aquacel AG
Hydrocellulose wound dressing containing 1.2% cationic silver
Aquacel
Hydrocellulose wound dressing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* partial thickness thermal (scald, contact, fire) burns up to 25% TBSA on the trunk and extremities
* presenting \< 72 hours after injury
Exclusion Criteria
* isolated burns to perineum, hands, or feet allergy to silver
* concomitant injury (eg.fractures)
* inhalational injury
* chemical burn
* electrical burn
* unable to understand English or French
* have not had a silver-based wound dressing applied prior to presentation
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IWK Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Bezuhly
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Bezuhly, MD, MSc, SM, FRCSC
Role: PRINCIPAL_INVESTIGATOR
IWK Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IWK Health Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1022040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.